[1][2] Such conditions include hemorrhagic shock, myocardial infarction (heart attack), and stroke.
[1] Diffusion Pharmaceuticals is currently investigating the use of trans sodium crocetinate in the treatment of COVID-19, acute stroke, and solid cancerous tumors.
[8] Oxygen diffusion-enhancing compounds are thought to act by exerting hydrophobic forces that interact with water molecules.
[9] These interactions result in greater hydrogen bonding among water molecules, which constitute the majority of the blood plasma medium.
[9][13] Computer simulations have shown that TSC specifically can increase the transport of oxygen through water by as much as 30 percent.